Small Vessel Disease: Perpetrator or Predictor of Stroke in Patients With Atrial Fibrillation?

Affiliations

¹ Department of Neurology, Regions Hospital Comprehensive Stroke Center, St. Paul, MN (H.M.H.).
² Department of Neurology, University of Minnesota, Minneapolis (D.C.A.).

Editorial

Haitham M Hussein et al. Stroke. 2021 Jan.

. 2021 Jan;52(1):100-102.

doi: 10.1161/STROKEAHA.120.032536. Epub 2020 Dec 7.

¹ Department of Neurology, Regions Hospital Comprehensive Stroke Center, St. Paul, MN (H.M.H.).
² Department of Neurology, University of Minnesota, Minneapolis (D.C.A.).

No abstract available

Keywords: Editorials; anticoagulants; atrial fibrillation; heart failure; hypertension.

Comment on

Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
Du H, Wilson D, Ambler G, Banerjee G, Shakeshaft C, Cohen H, Yousry T, Al-Shahi Salman R, Lip GYH, Houlden H, Brown MM, Muir KW, Jäger HR, Werring DJ; Clinical Relevance of Microbleeds in Stroke (CROMIS-2) Collaborators. Du H, et al. Stroke. 2021 Jan;52(1):91-99. doi: 10.1161/STROKEAHA.120.029474. Epub 2020 Dec 7. Stroke. 2021. PMID: 33280548